ロード中...
Prevalence of CTR1 and ERCC1 Polymorphisms and Response of Biliary Tract Cancer to Gemcitabine-Platinum Chemotherapy
PURPOSE: Biliary tract cancer (BTC)is an aggressive disease with a poor prognosis. Most patients are diagnosed at an advanced stage for which curative surgery is not possible and gemcitabine-platinum chemotherapy is the treatment of choice for advanced cases. Several studies had focused on biomarker...
保存先:
| 出版年: | Asian Pac J Cancer Prev |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
West Asia Organization for Cancer Prevention
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5464510/ https://ncbi.nlm.nih.gov/pubmed/28443323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2017.18.3.857 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|